Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2017-07-31 Earnings Release
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated July 31, 2017, from Medpace Holdings, Inc. It announces the issuance of a press release with financial results for the three and six months ended June 30, 2017. The text explicitly states that the press release is furnished as an exhibit and posted on the company's website. The document itself does not contain detailed financial statements or substantive financial data but rather serves as a notification of the earnings release. According to the 'Menu vs Meal' rule, such a short document announcing the release of financial results and attaching a press release should be classified as an Earnings Release (ER). The document is not the full earnings report but the initial announcement of quarterly financial results.
2017-07-31 English
AMENDMENT NO. 1 TO SCHEDULE 13D
Major Shareholding Notification
2017-06-22 English
FORM 3 SUBMISSION
Director's Dealing
2017-06-22 English
FORM 4 SUBMISSION
Director's Dealing
2017-06-22 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a credit agreement and pledge of shares related to financing activities, including a margin loan and pledge of common stock as collateral. This is an update on the company's financing and capital structure, not a full financial report or earnings release. The document is not a report publication announcement or certification but a substantive disclosure of a financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2017-06-21 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 14, 2017, reporting changes in the company's board of directors and appointments of new directors. It details resignations of two board members and the election of two new directors, including their backgrounds and compensation arrangements. The content focuses exclusively on board and management changes without financial data or other report types. Therefore, this filing fits the category of Board/Management Information (MANG). The document length is 5695 characters, sufficient to contain substantive information rather than a brief announcement. Hence, the classification is MANG with high confidence.
2017-06-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.